Diabetes complications

Methylamine metabolites and progression to kidney failure in type 2 diabetes: An Asian and European prospective study

Diabetes MetabPublished Prospective cohort study

Authors' conclusion

Plasma choline is an independent risk factor for DKD progression in two independent type 2 diabetes populations. Interventional trials are needed to assess whether reducing dietary choline intake could mitigate severe renal outcomes in type 2 diabetes.

Study context

Population
Patients with T2D of two ethnic backgrounds; baseline plasma betaine, carnitine, choline, trimethylamine and TMAO measured by mass-spectrometry
Participants
1,357 vs 1,868
Exposure
Per 1 SD higher plasma methylamine metabolite concentration
  • SURDIAGENEn = 1,357
  • KTPH-DKDn = 1,868
Outcome
SURDIAGENE: composite of sustained doubling of serum creatinine or kidney failure with replacement therapy (KFRT); KTPH-DKD: KFRT
Follow-up
Median 7.1 years (IQR 4.5-10.7) in SURDIAGENE; 10.7 years (IQR 7.0-11.8) in KTPH-DKD
Methodological detailstwo independent cohorts, European and Asian origin
  • Two independent cohorts
  • European and Asian origin

Main finding

As reported in the abstract

GroupValueHR per 1 SD choline, composite renal outcomeHR per 1 SD choline, kidney failure with replacement therapy (KFRT)
SURDIAGENE75 events1.29 [1.02;1.62], P = 0.033
KTPH-DKD149 events1.84 [1.30;2.61], P < 0.001

Value

SURDIAGENE75 events
KTPH-DKD149 events

HR per 1 SD choline, composite renal outcome

SURDIAGENE1.29 [1.02;1.62], P = 0.033
KTPH-DKD— not stated in the abstract

HR per 1 SD choline, kidney failure with replacement therapy (KFRT)

SURDIAGENE— not stated in the abstract
KTPH-DKD1.84 [1.30;2.61], P < 0.001

Observational data: associations, not effects.

Secondary outcomes

40% renal function loss (RFL40), SURDIAGENE
1.11 [1.01;1.23], P = 0.028 · HR per 1 SD choline

Original publication

Methylamine metabolites and progression to kidney failure in type 2 diabetes: An Asian and European prospective study. Diabetes Metab. Published 30 April 2025. doi:10.1016/j.diabet.2025.101658

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.